Latest article
UArizona researcher finds a novel method to sort out each Alzheimer’s illness and diabetes
A researcher from the University of Arizona Health Sciences studied the role...
Fierce Pharma Asia—AstraZeneca-Junshi PD-1 deal; Takeda’s $1.2B diabetes selloff, Ovid epilepsy collab pullout
In a strangely structured deal, AstraZeneca has nationwide licensed Junshi Biosciences' PD-1 inhibitor for only one indication in China. Takeda continued to sell...
Does diabetes qualify for vaccine precedence in Mass.? Relies on which kind.
A number of studies published in the past few months suggest that people with type 1 and type 2 diabetes are at roughly the...